Webinar: Managing High Risk Uveitis Patients During the COVID-19 Pandemic
Recorded on Thursday 9th April
Many uveitis patients are receiving immunosuppressive therapies, and Dr Millicent Stone discusses how the clinical presentation of the viral infection may affect these patients.
Another issue is related to the re-organisation of ophthalmology services during this time to guarantee safe delivery of ophthalmic care, while protecting patients from unnecessary exposure to the virus. Dr Harry Petrushkin describes how Moorfields Eye Hospital has changed the way it works.
A final topic will be the management strategies to deal with your patients. Which changes had to be implemented in view of the pandemic and how best to use systemic and local approaches for the management of sight-threatening non-infectious posterior uveitis. Dr Laura Steeples addresses this important aspect of our daily practice.
- Effect of Immunosuppressive Therapy on COVID-19 – Dr Millicent Stone
- Service Reorganisation During COVID-19 – Dr Harry Petrushkin
- Management of Sight-threatening Posterior Uveitis During COVID-19 – Dr Laura Steeples
Dr Millicent Stone
Guys & St Thomas’ Hospital
Dr Stone is a Consultant Rheumatologist at Guys and St Thomas’s NHS Foundation Trust.
She is an expert in inflammatory eye diseases and immunosuppressive agents and has a unique role at St Thomas’ appointed into the Department of Ophthalmology as a Rheumatologist
She is also Founder of, iOWNA a medical digital technology company, whose digital platform enables clinicians to deliver trusted guidance to their patients with chronic diseases particularily in the light of current COVID19 pandemic.
Millicent is a key opinion leader in her field and has published in top quality peer review journals and held prestigious peer review grants in the UK, Canada and USA and won many prizes for her research in clinical outcomes including BMA Doris Hilier Award.
Dr Harry Petrushkin
Mr Harry Petrushkin studied medicine at Cambridge University and Kings College London. He carried out much of his ophthalmic training in Moorfields Eye Hospital, with Mr Carlos Pavesio and St Thomas’ Hospital with Prof Miles Stanford where he developed his interest in inflammatory eye disease.
This led to a PhD, which he carried out at Queen Mary University London, in the Behcet’s Disease Centre of Excellence with Prof Farida Fortune, studying the immunogenetics of Behcet’s Disease. In 2016, Harry travelled to the United States, and spent time at the Francis Proctor Eye Institute, San Francisco, CA with Prof Nisha Acharya; the Casey Eye Institute, Portland, OR with Prof James Rosenbaum and the Massachusetts Eye Research and Surgery Institute, Boston, MA with Prof Steven Foster.
He currently works as a consultant ophthalmologist at Moorfields Eye Hospital and Great Ormond St Hospital managing inflammatory eye disease in adults and children.
Dr Laura Steeples
Laura has been an investigator in several national and international clinical trials. She has over 40 publications in peer reviewed journals and regularly presents at national and international meetings. She is a contributing member to the UK Uveitis National Clinical Study Group.
Dr Carlos Pavesio is a Consultant Ophthalmic Surgeon for the Medical Retinal Service at Moorfields Eye Hospital, London, UK. He was the Medical Retina Service Director between 2008 and 2016. He is also an honorary Clinical Lecturer and Uveitis theme leader for the Biomedical Research Centre, Institute of Ophthalmology, London and Honorary Consultant Ophthalmologist at St Thomas’s Hospital in London. He has just been appointed Director of the Fellowship Programme at Moorfields Eye Hospital.
Dr Pavesio is a member of many international ophthalmological societies. He was a board member for the SOE and EUPO (European Union of Professors of Ophthalmology).
For more than 10 years he has been the organiser of the Uveitis Programme for EURETINA and SOE, apart from having organised more than 10 International Uveitis Courses, both in the UK and abroad.
Dr Pavesio is the Editor-in-Chief for the Journal of Ophthalmic Inflammation and Infection and a member of the editorial board of the British Journal of Ophthalmology, Ocular Immunology and Inflammation, International Ophthalmology, and Journal of Ocular Infections and Inflammation and Ophthalmology.
Job code: UK-ILV-MMM-1649
This educational and promotional meeting has been organised and funded by Alimera Sciences.
This website is intended for UK healthcare professionals only.
Date of preparation: April 2020